Omega 3 Market [By Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-Linolenic Acid (ALA)); By Source (Plant Sources, Marine Sources, Others); By Application (Functional Food and Supplements, Pharmaceutical, Infant Formula, Animal Feed, Others); By Region]: Market Size & Forecast, 2017 – 2026

  • Report Id: PMR-9984
  • Category: Food & Beverages
  • Published Date: Jan 2018
  • Pages: 75
According to a new report published by Polaris Market Research the Omega 3 market is anticipated to reach over USD 4,262.5 million by 2026. In 2017, the functional food and supplements segment dominated the global market, in terms of revenue. North America was the leading contributor to the global market revenue in 2017.



A significant increase in awareness regarding a healthy diet, changing lifestyles, and health benefits offered by Omega 3 drive the growth of this market. Other driving factors include growing inclination towards use of natural and organic products, and increasing use of Omega 3 in functional food and pharmaceutical. Increasing demand from developing nations is expected provide numerous growth opportunities to the market players during the forecast period.



There has been a growing awareness regarding health benefits offered by Omega 3 among consumers. Omega 3 assists in body functions such as muscle activity, brain development and functioning, blood clotting, digestion, fertility, and cell division and growth, which has increased its adoption. Use of EPA also helps in controlling anxiety, depression and other related health problems.



Improvement in lifestyle due to rise in income level, especially in the developing countries of Asia-Pacific fuels the demand for Omega 3 market. Factors such as increase in per capita income, changes in consumer behavior, and increased awareness regarding health and nutrition are expected to accelerate the adoption of Omega 3 in the coming years.



North America generated the highest revenue in the market in 2017. The increasing geriatric population in the region coupled with high disposable income drives the market growth. The increasing demand of Omega 3 in the region is owing to high consumer awareness regarding the benefits of Omega 3, and growing health concerns. Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to increasing disposable incomes in developing countries of this region, and rising demand of Omega 3 for infant formula, animal feed, and pharmaceutical.



The different applications of Omega 3 include functional food and supplements, pharmaceutical, infant formula, animal feed, and others. In 2017, functional food and supplements segment accounted for the highest market share. Use of omega 3 in functional food and supplements provide proper nutrition and enable efficient functioning of human bodies. The increasing demand of functional food and supplements from athletes and sports sector further supports market growth.



The well-known companies profiled in the report include Omega Protein Corporation, Croda International PLC, Arista Industries Inc., Cargill, Inc., Royal DSM, Pharma Marine AS, GC Reiber Oils, Nordic Naturals Inc., Reckitt Benckiser Group plc, Pharma Nord B.V., Pharmavite LL, and Natrol LLC among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Omega 3 Market Insights
3.1. Omega 3 – Industry snapshot
3.2. Omega 3 - Ecosystem analysis
3.3. Omega 3 Market Dynamics
3.3.1. Omega 3 – Market Forces
3.3.1.1. Omega 3 Market Driver Analysis
3.3.1.2. Omega 3 Market Restraint/Challenges analysis
3.3.1.3. Omega 3 Market Opportunity Analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Omega 3 Market PEST Analysis, 2016
3.3.4. Omega 3 Market Value Chain Analysis
3.3.5. Omega 3 Industry Trends
3.3.6. Competitive Ranking Analysis
4. Omega 3 Market Size and Forecast, 2017-2026 by Type
4.1. Key Findings
4.2. Docosahexaenoic Acid (DHA)
4.3. Eicosapentaenoic Acid (EPA)
4.4. Alpha-Linolenic Acid (ALA)
5. Omega 3 Market Size and Forecast, 2017-2026 by Source
5.1. Key Findings
5.2. Plant Sources
5.3. Marine Sources
5.4. Others
6. Omega 3 Market Size and Forecast, 2017-2026 by Application
6.1. Key Findings
6.2. Functional Food and Supplements
6.3. Pharmaceutical
6.4. Infant Formula
6.5. Animal Feed
6.6. Others
7. Omega 3 Market Size and Forecast, 2017-2026 by Region
7.1. Key Findings
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. UK
7.3.3. France
7.3.4. Italy
7.3.5. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Rest of Asia-Pacific
7.5. Latin America
7.5.1. Brazil
7.6. Middle East & Africa
8. Company Profiles
8.1. Omega Protein Corporation
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Benchmarking
8.1.4. Recent Developments
8.2. Croda International PLC
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Benchmarking
8.2.4. Recent Developments
8.3. Arista Industries Inc.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Benchmarking
8.3.4. Recent Developments
8.4. Cargill, Inc.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Benchmarking
8.4.4. Recent Developments
8.5. Royal DSM
8.5.1. Overview
8.5.2. Financials
8.5.3. Product Benchmarking
8.5.4. Recent Developments
8.6. Pharma Marine AS
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Benchmarking
8.6.4. Recent Developments
8.7. GC Reiber Oils
8.7.1. Overview
8.7.2. Financials
8.7.3. Product Benchmarking
8.7.4. Recent Developments
8.8. Nordic Naturals Inc.
8.8.1. Overview
8.8.2. Financials
8.8.3. Product Benchmarking
8.8.4. Recent Developments
8.9. Reckitt Benckiser Group plc
8.9.1. Overview
8.9.2. Financials
8.9.3. Product Benchmarking
8.9.4. Recent Developments
8.10. Pharma Nord B.V.
8.10.1. Overview
8.10.2. Financials
8.10.3. Product Benchmarking
8.10.4. Recent Developments
8.11. Pharmavite LL
8.11.1. Overview
8.11.2. Financials
8.11.3. Product Benchmarking
8.11.4. Recent Developments
8.12. Natrol LLC
8.12.1. Overview
8.12.2. Financials
8.12.3. Product Benchmarking
8.12.4. Recent Developments

List of Figures